Double bottom in GILDWonderful double bottom pattern spotted in GILD. It hasn't broken out yet. This chart is for educational purposes only. Please consult your financial advisor before making any buy or sell decision.
4.54USD
5.66 BUSD
27.06 BUSD
1.25 B
About Gilead Sciences, Inc.
Sector
Industry
CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Employees (FY)
18 K
Founded
1987
ISIN
US3755581036
FIGI
BBG000CKGBP2
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Gildgilead science is in parallel channel since last 6 years and forming bearish downward pattern.
This is not good as follow through for the long pole is missing.
Manage risks and Own profitsHere's a rotated Trade Box For GLD
PLease refere to old trade boxes to get a keymap or feel free to PM!
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where GILD is featured.
Frequently Asked Questions
The current price of GILD is 66.76 USD — it has increased by 0.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gilead Sciences, Inc. stocks are traded under the ticker GILD.
Gilead Sciences, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
GILD stock is 1.01% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is Gilead Sciences, Inc. there?
One year price forecast for Gilead Sciences, Inc. has a max estimate of 120.00 USD and a min estimate of 69.00 USD.
GILD earnings for the last quarter are 2.29 USD per share, whereas the estimation was 1.92 USD resulting in a 19.50% surprise. The estimated earnings for the next quarter are 1.76 USD per share. See more details about Gilead Sciences, Inc. earnings.
Gilead Sciences, Inc. revenue for the last quarter amounts to 7.05 B USD despite the estimated figure of 6.81 B USD. In the next quarter revenue is expected to reach 7.10 B USD.
Yes, you can track Gilead Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
GILD stock has fallen by 2.57% compared to the previous week, the month change is a 8.88% fall, over the last year Gilead Sciences, Inc. has showed a 20.29% decrease.
GILD net income for the last quarter is 1.43 B USD, while the quarter before that showed 2.18 B USD of net income which accounts for −34.45% change. Track more Gilead Sciences, Inc. financial stats to get the full picture.
Today Gilead Sciences, Inc. has the market capitalization of 82.50 B, it has decreased by 3.61% over the last week.
Yes, GILD dividends are paid quarterly. The last dividend per share was 0.77 USD. As of today, Dividend Yield (TTM)% is 4.56%. Tracking Gilead Sciences, Inc. dividends might help you take more informed decisions.
Gilead Sciences, Inc. dividend yield was 3.70% in 2023, and payout ratio reached 66.62%. The year before the numbers were 3.40% and 80.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gilead Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 18.00 K employees. See our rating of the largest employees — is Gilead Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gilead Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gilead Sciences, Inc. stock shows the sell signal. See more of Gilead Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Gilead Sciences, Inc. future price: according to them, GILD price has a max estimate of 120.00 USD and a min estimate of 69.00 USD. Read a more detailed Gilead Sciences, Inc. forecast: see what analysts think of Gilead Sciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gilead Sciences, Inc. EBITDA is 11.88 B USD, and current EBITDA margin is 45.96%. See more stats in Gilead Sciences, Inc. financial statements.